Trulieve Cannabis Corp Ordinary Shares (Sub Voting) TRUL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TRUL is a good fit for your portfolio.
News
-
Cannabis stocks pull back after rallying on DEA's plans to reclassify marijuana
-
Cannabis stocks rally after report that DEA will reclassify drug as less dangerous
-
Trulieve to Open Medical Cannabis Dispensary in North Palm Beach, Florida
-
Trulieve Cannabis Corp. to Hold First Quarter 2024 Results Conference Call on May 9, 2024
-
Trulieve Announces April 2024 Event Participation
-
Florida Supreme Court OKs adult-use cannabis referendum for November ballot in victory for pot companies
-
Trulieve Applauds Florida Supreme Court for Affirmative Ruling on the Smart & Safe Florida Ballot Initiative
-
Trulieve to Open Medical Cannabis Dispensary in Cocoa Beach, Florida
Trading Information
- Previous Close Price
- CAD 16.51
- Day Range
- CAD 16.25–17.38
- 52-Week Range
- CAD 4.66–20.00
- Bid/Ask
- CAD 16.30 / CAD 17.09
- Market Cap
- CAD 3.13 Bil
- Volume/Avg
- 272,489 / 313,634
Key Statistics
- Price/Earnings (Normalized)
- 73.82
- Price/Sales
- 2.07
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Trulieve Cannabis Corp is a vertically integrated seed to sale and fully licensed medical marijuana company. It is mainly engaged in the cultivation, possession, use, sale, and distribution of medical cannabis.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 5,400
- Website
- https://www.trulieve.com
Comparables
Valuation
|
Metric
|
TRUL
|
BKUH
|
ISPR
|
|---|---|---|---|
Price/Earnings (Normalized) | 73.82 | — | — |
Price/Book Value | 1.66 | — | 10.15 |
Price/Sales | 2.07 | — | 1.98 |
Price/Cash Flow | 84.26 | — | — |
Price/Earnings
TRUL
BKUH
ISPR
Financial Strength
|
Metric
|
TRUL
|
BKUH
|
ISPR
|
|---|---|---|---|
Quick Ratio | 1.87 | 0.14 | 1.24 |
Current Ratio | 4.16 | 0.14 | 1.42 |
Interest Coverage | −2.56 | −7.04 | — |
Quick Ratio
TRUL
BKUH
ISPR
Profitability
|
Metric
|
TRUL
|
BKUH
|
ISPR
|
|---|---|---|---|
Return on Assets (Normalized) | −3.80% | 174.31% | −5.37% |
Return on Equity (Normalized) | −7.03% | — | −12.93% |
Return on Invested Capital (Normalized) | −2.14% | — | −12.48% |
Return on Assets
TRUL
BKUH
ISPR
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Jpnltpyxq | Vryy | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Hphxpktp | Pwrbnl | $69.1 Bil | |
HLN
| Haleon PLC ADR | Ssnlvlnl | Fxkh | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Pnghzkzf | Ckqn | $15.6 Bil | |
VTRS
| Viatris Inc | Vqghkjnp | Xsfnt | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Vjcmghsw | Vnqy | $12.4 Bil | |
CTLT
| Catalent Inc | Lmlxwmy | Qyqjcxd | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Klnqlbbz | Bsv | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Zqyzxbqb | Vtfh | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Fzjfwhjd | Rxnng | $3.5 Bil |